Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Smits MM, Holst JJ
Why Joint Pain May Occur During GLP-1 Treatment Rapid weight loss altering joint biomechanics is the most likely indirect cause of joint pain during GLP-1 treatment, rather than a direct drug effect
Injection site reactions, unusual fatigue , dizziness , and gastrointestinal symptoms beyond what the drug typically causes could indicate contamination
8 The GlyNAC combination (glycine + NAC, addressing both rate-limiting precursors simultaneously) produced particularly robust results in a 16-week, placebo-controlled RCT in older adults: it corrected glutathione deficiency, reduced oxidative stress, improved mitochondrial fatty-acid oxidation, and enhanced physical performance measures including gait speed and the 6-minute walk test
